Odenthal, Germany

Wolfgang Karl


Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Wolfgang Karl from Odenthal, DE

Introduction

Wolfgang Karl is an accomplished inventor based in Odenthal, Germany. He holds three patents, each contributing significantly to the field of medicinal chemistry and central nervous system treatments. His innovative work embodies the spirit of scientific advancement and dedicated research.

Latest Patents

One of Wolfgang Karl's notable patents is titled "Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system." This invention focuses on chromans and their preparation processes, emphasizing their potential use in developing medicaments aimed at treating disorders affecting the central nervous system.

Another significant patent by Karl involves "Methods for decomposing quinolones and naphthyridones." This innovation showcases his expertise in addressing complex chemical compounds, further indicating his commitment to improving therapeutic solutions.

Career Highlights

Throughout his career, Wolfgang Karl has been affiliated with prominent pharmaceutical corporations such as Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. His tenure at these organizations has allowed him to explore advanced medicinal chemistry, contributing to various projects that enhance health outcomes through innovative drug development.

Collaborations

Karl has collaborated with notable colleagues, including Dietrich Scherling and Dietrich Seidel. These partnerships have facilitated a dynamic exchange of ideas and techniques, fostering a collaborative environment that stimulates innovation and progress in their respective fields.

Conclusion

In conclusion, Wolfgang Karl's contributions to medicinal chemistry, as evidenced by his patents and collaborations, signify his valuable presence in the innovation landscape. His work continues to impact the research community, providing new avenues for treating critical health issues affecting the central nervous system.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…